405 results
Page 2 of 21
S-8
EX-4.5
qnfy32jx ivbb5d
22 Feb 24
Registration of securities for employees
5:50pm
424B5
sxzi280
21 Feb 24
Prospectus supplement for primary offering
8:39am
8-K
EX-99.1
84ays j93us
2 Feb 24
AbbVie Reports Full-Year and Fourth-Quarter 2023 Financial Results
7:51am
8-K
mtdlqq9eb7hma0dzrx4
5 Jan 24
Guidance Including the Impact of Acquired IPR&D and Milestones Expense
4:03pm
8-K
EX-99.1
lmf2dhw
27 Oct 23
AbbVie Reports Third-Quarter 2023 Financial Results
7:49am
8-K
4xbu9ylx
4 Oct 23
Guidance Including the Impact of Acquired IPR&D and Milestones Expense
4:11pm
8-K
EX-99.1
rxas2jg3zz h9ai
27 Jul 23
AbbVie Reports Second-Quarter 2023 Financial Results
7:45am
8-K
4lz b5xsgqkcov
6 Jul 23
Guidance Including the Impact of Acquired IPR&D and Milestones Expense
4:18pm
11-K
lk24z8
28 Jun 23
Annual report of employee stock purchases
5:00pm